Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-07-19

Clinical Trial Update: Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating etanercept in three subtypes of juvenile idiopathic arthritis has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etanercept (etanercept)

Snippet

Sponsor: Pfizer | Conditions: Arthritis, Juvenile Idiopathic | Phase 3 | Status: COMPLETED | Results posted: 2012-07-19